Navigation Links
Caris Life Sciences to Present Molecular Insights Informing Treatment Strategies at the 2016 Society of Gynecologic Oncology Annual Meeting
Date:3/15/2016

IRVING, Texas, March 15, 2016 /PRNewswire/ -- Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, announced today that the company will present seven poster presentations at the 2016 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancers from March 19-22, 2016 in San Diego, Calif. One of the seven studies, which identified biomarkers implicating drug resistance and alternate treatment options in uterine leiomyosarcomas, was awarded featured poster status.

Each of the studies being presented were conducted in collaboration with leading academic and clinical institutions across the nation, including New York-Presbyterian, Columbia University Medical Center, Weill Cornell Medical College and Fox Chase Cancer Center. The collective set of studies utilized Caris Molecular Intelligence® (CMI), the company's patented and proprietary offering to help physicians make informed therapy decisions, which facilitated biomarker identification and molecular characterization of rare and aggressive gynecologic cancers across different subtypes. The use of CMI enabled investigators to identify the molecular heterogeneity of gynecologic cancers and inform physicians on therapeutic options, including therapies with potential benefit to consider and, just as important, therapies to avoid due to potential lack of benefit.

Following is a schedule of Caris Life Sciences' poster presentations:Title: Uterine leiomyosarcomas exhibit distinct drug resistance molecular profiles compared to extrauterine leiomyosarcomas: A comprehensive analysis of 1,023 leiomyosarcomasDate and Time: Sunday March 20, 2016 and Monday, March 21, 2016 from 10:25–10:45 a.m. PTAbstract #:124Location:Hall B1Session:Featured Poster Session IAuthors:Sudeshna Chatterjee, Joanne Xiu, Sandeep Reddy, Nathaniel Jones, Alexandre Buckley de Meritens, Ana Tergas, William Burke, Jason Wright, June HouCollaborators:NewYork-Presbyterian Hospital, Columbia University Medical Center, Weill Cornell Medical College, Columbia University College of Physicians and Surgeons


 Title:Vulvar and vaginal melanoma: A distinct subclass of melanoma based on a comprehensive molecular analysis of 51 casesDate and Time: Sunday March 20, 2016 and Monday, March 21, 2016 from 8:45–9:05 a.m. PTAbstract #:257Location:Hall B1Session:Poster Session 1Authors:Caitlin Baptiste, William Burke, Rebecca Feldman, Jason Wright, Ana Tergas, June HouCollaborators:New York-Presbyterian Hospital, Columbia University Medical Center, Columbia University College of Physicians and Surgeons


 Title:Identification of molecular targets in vulvar cancersDate and Time:Sunday March 20, 2016 and Monday, March 21, 2016 from 12:25–12:45 p.m. PTAbstract #:271Location:Hall B1Session:Poster Session 1Authors:Premal Thaker, Marguerite Palisoul, Sandeep Reddy, Rebecca FeldmanCollaborator: 

Washington University School of Medicine in St. Louis


 Title:Multiplatform tumor-profiling of 43 malignant Sertoli-Leydig cell tumors of the ovary reveals therapeutic opportunitiesDate and Time: Sunday March 20, 2016 and Monday, March 21, 2016 from 2:45–3:05 p.m. PTAbstract #:267Location:Hall B1Session:Poster Session 1Authors:Joanne Xiu, Sandeep Reddy, Christina ChuCollaborator:Fox Chase Cancer Center


 Title:Unique molecular signatures between high-grade and low-grade endometrial stromal sarcoma: An analysis of 96 casesDate and Time: Sunday March 20, 2016 and Monday, March 21, 2016 from 6:45–7:05 p.m. PTAbstract #:379Location:Hall B1Session:Poster Session 1Authors:Nathaniel Jones, Joanne Xiu, Sandeep Reddy, Sudeshna Chatterjee, Alexandre Buckley de Meritens, Ana Tergas, William Burke, Jason Wright, June HouCollaborators: New York-Presbyterian, Columbia University Medical Center, Weill Cornell Medical College, Columbia University College of Physicians and Surgeons


 Title:Molecular profiling of triple-negative endometrial cancers and triple-negative breast cancers reveals unique expression profiles Date and Time: Sunday, March 20, 2016 and Monday, March 21, 2016 from 7:05–7:25 p.m. PTAbstract #:166Location:Hall B1Session:Poster Session 1Authors:Nathaniel Jones, Joanne Xiu, Sandeep Reddy, Sudeshna Chatterjee, Alexandre Buckley de Meritens, Ana Tergas, William Burke, Jason Wright, June HouCollaborators: New York-Presbyterian, Columbia University Medical Center, Weill Cornell Medical College, Columbia University College of Physicians and Surgeons


 Title:Molecular profiling reveals distinct molecular landscape in 545 cases of triple-negative endometrial cancerDate and Time:Sunday March 20, 2016 and Monday, March 21, 2016 from 9:45–10:05 p.m. PTAbstract #:167Location: Hall B1Session:Poster Session 1Authors:Nathaniel Jones, Joanne Xiu, Sandeep Reddy, Alexandre Buckley de Meritens, Sudeshna Chatterjee, Ana Tergas, William Burke, Jason Wright, June HouCollaborators: New York-Presbyterian, Columbia University Medical Center, Weill Cornell Medical College, Columbia University College of Physicians and Surgeons

 

About Caris Life Sciences®
Founded by David D. Halbert in 2008, Caris Life Sciences® is a leading biotechnology company focused on fulfilling the promise of precision medicine through quality and innovation. Caris Molecular Intelligence®, the company's patented offering to help physicians make more informed therapy decisions, with more than 85,000 patients profiled, provides oncologists with the most clinically actionable treatment options available to personalize cancer care today. Using a variety of advanced profiling technologies to assess relevant biological changes in each patient's tumor, Caris Molecular Intelligence connects biomarker data generated from a tumor with biomarker-drug associations supported by evidence in the relevant clinical literature through a proprietary bioinformatics rules engine. Since 2009, Caris Life Sciences has tracked clinical and outcome data for certain patients undergoing tumor profiling, and has observed that patients treated with drugs consistent with their tumor profile show a significant increase in overall survival. The company is also developing its ADAPT Biotargeting System, a revolutionary and unbiased profiling platform with applications across therapy development, drug delivery, advanced diagnostics and disease monitoring. Currently being developed for cancer and other complex diseases, the ADAPT Biotargeting System is able to simultaneously measure millions of molecular interactions within complex biological systems in their natural state(s). Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Australia and other international markets. To learn more, please visit www.CarisLifeSciences.com

 


'/>"/>
SOURCE Caris Life Sciences
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Caris Life Sciences Announces Planned Expansion of Next-Generation Sequencing (NGS) Capabilities
2. Caris Life Sciences ASCO Presentation Highlights the Utility of Molecular Profiling for the Management of Rare and Aggressive Cancers
3. Caris Life Sciences Presents Key Biomarker Data at 2013 Association for Molecular Pathology (AMP) Annual Meeting
4. Caris Life Sciences Receives Patent for Molecular Profiling Service in The Peoples Republic of China
5. Caris Life Sciences erhält erste Akkreditierung als medizinisches Laboratorium nach ISO 15189 im Bereich Tumor-Profiling
6. Feist-Weiller Cancer Center Partners With Caris Life Sciences to Establish a Clinical Molecular Profiling Program
7. Caris Life Sciences Study Shows Molecular Profiling May Expand Use of PD-1 and PD-L1 Inhibitors to Wide Variety of Cancers
8. Caris Life Sciences Reports Record-Setting 2014 Year-End Results
9. Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options
10. Caris Life Sciences Announces Presentation of Comprehensive Tumor Profiling Research at 2015 Society of Gynecologic Oncology (SGO) Annual Meeting
11. Caris Life Sciences Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... Worth, Texas (PRWEB) , ... September 20, 2017 , ... ... stem cell therapy succeeded after standard medicine failed. Many of these people had lost ... Progress, Not Regression Free Download (pdf) , “Neil takes ...
(Date:9/19/2017)... ... 2017 , ... A best-selling author and an international law ... Angela Duckworth and her team at Character Lab have joined Philadelphia’s ic@3401 as ... firm with decades of experience supporting high-growth companies in the technology and life ...
(Date:9/19/2017)... Ann Arbor, MI (PRWEB) , ... September 19, ... ... chemical testing laboratory, is pleased to announce the recipients of its 2017 Science ... academic achievement, exceptional leadership qualities, and involvement with community service defray the costs ...
(Date:9/18/2017)... USA, and CARDIFF, UK (PRWEB) , ... September ... ... for optics and photonics, has announced the move of the SPIE Digital Library ... , Developed internally by SPIE to create an improved user experience and incorporate ...
Breaking Biology Technology:
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):